These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6883349)

  • 1. Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer.
    Bunn PA; Carney DN; Gazdar AF; Whang-Peng J; Matthews MJ
    Cancer Res; 1983 Oct; 43(10):5026-32. PubMed ID: 6883349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of model chromosome number of cultured non-small cell lung carcinomas with DNA index of solid tumor tissue.
    Siegfried JM; Ellison DJ; Resau JH; Miura I; Testa JR
    Cancer Res; 1991 Jun; 51(12):3267-73. PubMed ID: 1645617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and problems of flow cytometric nuclear DNA content analysis in lung cancer using bronchoscopically-obtained specimens].
    Ariyoshi I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1704-10. PubMed ID: 1333022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
    Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
    Teodori L; Tirindelli-Danesi D; Mauro F; De Vita R; Uccelli R; Botti C; Modini C; Nervi C; Stipa S
    Cytometry; 1983 Sep; 4(2):174-83. PubMed ID: 6313307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
    Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
    Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K; Hayashi Y; Nagao S; Watanabe Y
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric studies of human brain tumors. Part 4: Metastatic tumors].
    Oka N; Kawamoto K; Nishiyama T; Kawakami K; Nakajima T; Kawamura Y; Matsumura H; Tamaki N; Matsumoto S
    No Shinkei Geka; 1984 Oct; 12(11):1255-62. PubMed ID: 6514124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA content and clinical outcome in patients with non-small cell lung cancer given postoperative radiation therapy.
    Yu J; Shaeffer J; Zhu A; Kuban DA; el-Mahdi AM; Philput CB
    Cytometry; 1993; 14(4):428-32. PubMed ID: 8390343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pleural effusions by flow-cytometric DNA analysis.
    Høstmark J; Vigander T; Skaarland E
    Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.
    Choma D; Daurès JP; Quantin X; Pujol JL
    Br J Cancer; 2001 Jul; 85(1):14-22. PubMed ID: 11437396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow immunocytochemistry of marker expression in cells from body cavity fluids.
    Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M
    Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients.
    Carney DN; Gazdar AF; Bunn PA; Guccion JG
    Stem Cells (1981); 1982; 1(3):149-64. PubMed ID: 6294885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
    Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
    Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.